Summary
This prediction ended on 06.02.23 with a price of €11.29. With a performance of 7.36%, the SELL prediction by BiotechBee for Snap Inc was trending in the wrong direction BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Snap Inc | -8.876% | -8.876% | -42.360% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
According to BiotechBee what are the pros and cons of Snap Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year